• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.[J].Journal Of Pharmaceutical Research,2026,45(8):895-903[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 450times   Download 429次 QR Code for this article
Scan with your phone!
GLP-1受体激动剂长效制剂的研究进展
张圣雯,何东升,涂家生
Font:Larger+|Default|Smaller-
(中国药科大学药学院药用辅料及仿创药物研发评价中心,江苏 南京 210009)
摘要:
关键词:  胰高血糖素样肽-1受体激动剂  2型糖尿病  肥胖  长效化策略
DOI:10.13506/j.cnki.jpr.2026.08.009
基金项目:国家自然科学基金项目(No.82003293)
Received Date:March 10, 2026   Revision Date:May 25, 2026   Publication Date:August 31, 2026
()
Abstract:
Key words:  
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.